Back
 OJU  Vol.2 No.4 , November 2012
Prognostic Factors and Oncological Outcomes after Radical Nephroureterctomy for Upper Tract Urothelial Carcinoma: Review of Contemporary Multi-Center Series
Abstract: Upper tract urothelial cancers (UTUC) are uncommon and the information guiding their management used to be driven from small single center studies. Multi-center international collaborations should provide clinicians with best management practices as well as prognostic factors guiding treatment decisions and outcomes. We reviewed literature from the largest multicenter collaborations for radical nephroureterctomy (RNU) performed for management of UTUC. Our review included over 50 recent manuscripts from 2009-2012 that were published from multi-center UTUC collaboration groups. Our review aims to determine of the prognostic factors predicting oncological outcomes after RNU and to provide insights about possible maximization of cure with utilization of multimodal treatment approaches. Application of approaches comprising RNU including lymphadenectomy and systemic chemotherapy; particularly in neoadjuvant settings; might have implications on improvement of oncological outcomes in high risk patients.
Cite this paper: R. F. Youssef, B. A. Gayed and V. Margulis, "Prognostic Factors and Oncological Outcomes after Radical Nephroureterctomy for Upper Tract Urothelial Carcinoma: Review of Contemporary Multi-Center Series," Open Journal of Urology, Vol. 2 No. 4, 2012, pp. 246-252. doi: 10.4236/oju.2012.24045.
References

[1]   A. Jemal, et al., “Cancer Statistics, 2010,” A Cancer Journal for Clinicians, Vol. 60, No. 5, 2010, pp. 277-300. doi:10.3322/caac.20073

[2]   M. Roupret, et al., “European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update,” European Urology, Vol. 59, No. 4, 2011, pp. 584-594.

[3]   V. Margulis, et al., “Outcomes of Radical Nephroureterectomy: A Series from the Upper Tract Urothelial Carcinoma Collaboration,” Cancer, Vol. 115, No. 6, 2009, pp. 1224-1233. doi:10.1002/cncr.24135

[4]   C. Gurbuz, et al., “The Impact of Previous Ureteroscopic Tumor Ablation on Oncologic Outcomes after Radical Nephrouretectomy for Upper Urinary Tract Urothelial Carcinoma,” Journal of Endourology, Vol. 25, No. 5, 2011, pp. 775-779. doi:10.1089/end.2010.0396

[5]   M. Adibi, et al., “Oncological Outcomes after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Comparison over the Three Decades,” International Journal of Urology, 2012.

[6]   S. F. Shariat, et al., “Advanced Patient Age Is Associated with Inferior Cancer-Specific Survival after Radical Nephroureterectomy,” BJU International, Vol. 105, No. 12, 2010, pp. 1672-1677. doi:10.1111/j.1464-410X.2009.09072.x

[7]   T. F. Chromecki, et al., “Chronological Age Is Not an Independent Predictor of Clinical Outcomes after Radical Nephroureterectomy,” World Journal of Urology, Vol. 29, No. 4, 2011, pp. 473-480. doi:10.1007/s00345-011-0677-0

[8]   M. I. Fernandez, et al., “Evidence-Based Sex-Related Outcomes after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: Results of Large Multicenter Study,” Urology, Vol. 73, No. 1, 2009, pp. 142-146. doi:10.1016/j.urology.2008.07.042

[9]   B. Ehdaie, et al., “Obesity Adversely Impacts Disease Specific Outcomes in Patients with Upper Tract Urothelial Carcinoma,” Journal of Urology, Vol. 186, No. 1, 2011, pp. 66-72. doi:10.1016/j.juro.2011.03.031

[10]   J. D. Raman, et al., “Does Preoperative Symptom Classification Impact Prognosis in Patients with Clinically Localized Upper-Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy?” Urologic Oncology, Vol. 29, No. 6, 2010, pp. 716-723.

[11]   C. K. Ng, et al., “Does the Presence of Hydronephrosis on Preoperative Axial CT Imaging Predict Worse Outcomes for Patients Undergoing Nephroureterectomy for Upper-Tract Urothelial Carcinoma?” Urologic Oncology, Vol. 29, No. 1, 2011, pp. 27-32. doi:10.1016/j.urolonc.2008.10.023

[12]   K. S. Cho, et al., “Grade of Hydronephrosis and Tumor Diameter as Preoperative Prognostic Factors in Ureteral Transitional Cell Carcinoma,” Urology, Vol. 70, No. 4, 2007, pp. 662-666. doi:10.1016/j.urology.2007.06.1106

[13]   C. J. Stimson, et al., “Preoperative Hydronephrosis Predicts Extravesical and Node Positive Disease in Patients Undergoing Cystectomy for Bladder Cancer,” Journal of Urology, Vol. 183, No. 5, 2010, pp. 1732-1737. doi:10.1016/j.juro.2010.01.028

[14]   J. C. Brien, et al., “Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma,” Journal of Urology, Vol. 184, No. 1, 2010, pp. 69-73. doi:10.1016/j.juro.2010.03.030

[15]   V. Margulis, et al., “Preoperative Multivariable Prognostic Model for Prediction of Nonorgan Confined Urothelial Carcinoma of the Upper Urinary Tract,” Journal of Urology, Vol. 184, No. 2, 2010, pp. 453-458. doi:10.1016/j.juro.2010.03.142

[16]   M. Roscigno, et al., “Lymphadenectomy at the Time of Nephroureterectomy for Upper Tract Urothelial Cancer,” European Urology, Vol. 60, No. 4, 2011, pp. 776-783.

[17]   M. Roscigno, et al., “Impact of Lymph Node Dissection on Cancer Specific Survival in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy,” Journal of Urology, Vol. 181, No. 6, 2009, pp. 2482-2489. doi:10.1016/j.juro.2009.02.021

[18]   M. Roscigno, et al., “The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed?” European Urology, Vol. 56, No. 3, 2009, pp. 512-518. doi:10.1016/j.eururo.2009.06.004

[19]   R. J. Mason, et al., “The Contemporary Role of Lymph Node Dissection during Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian Experience,” Urology, Vol. 79, No. 4, 2012, pp. 840-845. doi:10.1016/j.urology.2011.11.058

[20]   M. Roscigno, et al., “Assessment of the Minimum Number of Lymph Nodes Needed to Detect Lymph Node Invasion at Radical Nephroureterectomy in Patients with Upper Tract Urothelial Cancer,” Urology, Vol. 74, No. 5, 2009, pp. 1070-1074. doi:10.1016/j.urology.2009.04.084

[21]   M. Burger, et al., “No Overt Influence of Lymphadenectomy on Cancer-Specific Survival in Organ-Confined Versus Locally Advanced Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: A Retrospective International, Multi-Institutional Study,” World Journal of Urology, Vol. 29, No. 4, 2011, pp. 465-472. doi:10.1007/s00345-011-0705-0

[22]   G. Lughezzani, et al., “A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma,” Urology, Vol. 75, No. 1, 2010, pp. 118-124. doi:10.1016/j.urology.2009.07.1296

[23]   C. Bolenz, et al., “Risk Stratification of Patients with Nodal Involvement in Upper Tract Urothelial Carcinoma: Value of Lymph-Node Density,” BJU Intenational, Vol. 103, No. 3, 2009, pp. 302-306. doi:10.1111/j.1464-410X.2008.07988.x

[24]   H. Fajkovic, et al., “Prognostic Value of Extranodal Extension and Other Lymph Node Parameters in Patients with Upper Tract Urothelial Carcinoma,” Journal of Urology, Vol. 187, No. 3, 2012, pp. 845-851. doi:10.1016/j.juro.2011.10.158

[25]   E. Kikuchi, et al., “Lymphovascular Invasion Predicts Clinical Outcomes in Patients with Node-Negative Upper Tract Urothelial Carcinoma,” Journal of Clinical Oncology, Vol. 27, No. 4, 2009, pp. 612-618. doi:10.1200/JCO.2008.17.2361

[26]   G. Novara, et al., “Prognostic Role of Lymphovascular Invasion in Patients with Urothelial Carcinoma of the Upper Urinary Tract: An International Validation Study,” European Urology, Vol. 57, No. 6, 2010, pp. 1064-1071. doi:10.1016/j.eururo.2009.12.029

[27]   H. M. Fritsche, et al., “Macroscopic Sessile Tumor Architecture Is a Pathologic Feature of Biologically Aggressive Upper Tract Urothelial Carcinoma,” Urologic Oncology, Vol. 30, No. 5, 2010, pp. 666-672.

[28]   M. Remzi, et al., “Tumour Architecture Is an Independent Predictor of Outcomes after Nephroureterectomy: A Multi-Institutional Analysis of 1363 Patients,” BJU International, Vol. 103, No. 3, 2009, pp. 307-311. doi:10.1111/j.1464-410X.2008.08003.x

[29]   R. F. Youssef, et al., “Prognostic Effect of Urinary Bladder Carcinoma in situ on Clinical Outcome of Subsequent Upper Tract Urothelial Carcinoma,” Urology, Vol. 77, No. 4, 2011, pp. 861-866. doi:10.1016/j.urology.2010.09.032

[30]   J. C. Wheat, et al., “Concomitant Carcinoma in situ Is a Feature of Aggressive Disease in Patients with Organ Confined Urothelial Carcinoma Following Radical Nephroureterectomy,” Urologic Oncology, Vol. 30, No. 3, 2012, pp. 252-258. doi:10.1016/j.urolonc.2010.01.001

[31]   W. Otto, et al., “Concomitant Carcinoma in situ as an Independent Prognostic Parameter for Recurrence and Survival in Upper Tract Urothelial Carcinoma: A Multicenter Analysis of 772 Patients,” World Journal of Urology, Vol. 29, No. 4, 2011, pp. 487-494. doi:10.1007/s00345-011-0645-8

[32]   R. Zigeuner, et al., “Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract,” European Urology, Vol. 57, No. 4, 2010, pp. 575-581. doi:10.1016/j.eururo.2009.11.035

[33]   C. Seitz, et al., “Association of Tumor Necrosis with Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study,” Journal of Urology, Vol. 184, No. 5, 2010, pp. 1895-1900. doi:10.1016/j.juro.2010.06.106

[34]   J. D. Raman, et al., “Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy,” European Urology, Vol. 57, No. 6, 2010, pp. 1072-1079. doi:10.1016/j.eururo.2009.07.002

[35]   R. F. Youssef, et al., “Urothelial Carcinoma at the Uretero-Enteric Junction: Multi-Center Evaluation of Oncologic Outcomes after Radical Nephroureterectomy,” Urologic Oncology, 2011. http://dx.doi.org/10.1016/j.urolonc.2011.05.006

[36]   U. Capitanio, et al., “Comparison of Oncologic Outcomes for Open and Laparoscopic Nephroureterectomy: A Multi-Institutional Analysis of 1249 Cases,” European Urology, Vol. 56, No. 1, 2009, pp. 1-9. doi:10.1016/j.eururo.2009.03.072

[37]   T. J. Walton, et al., “Oncological Outcomes after Laparoscopic and Open Radical Nephroureterectomy: Results from an International Cohort,” BJU International, Vol. 108, No. 3, 2011, pp. 406-412. doi:10.1111/j.1464-410X.2010.09826.x

[38]   M. M. Ariane, et al., “Assessment of Oncologic Control Obtained after Open Versus Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinomas (UUT-UCs): Results from a Large French Multicenter Collaborative Study,” Annals of Surgical Oncology, Vol. 19, No. 1, 2012, pp. 301-308. doi:10.1245/s10434-011-1841-x

[39]   R. F. Youssef, et al., “Upper Urinary Tract Urothelial Carcinoma with Loco-Regional Nodal Metastases: Insights from the Upper Tract Urothelial Carcinoma Collaboration,” BJU International, Vol. 108, No. 8, 2011, pp. 1286-1291.

[40]   N. J. Hellenthal, et al., “Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration,” Journal of Urology, Vol. 182, No. 3, 2009, pp. 900-906. doi:10.1016/j.juro.2009.05.011

[41]   A. Bagrodia, et al., “Prospective Evaluation of Molecular Markers for the Staging and Prognosis of Upper Tract Urothelial Carcinoma,” European Urology, Vol. 62, No. 1, 2012, pp. 27-29. doi:10.1016/j.eururo.2012.04.031

 
 
Top